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Abstract
Chronic traumatic encephalopathy (CTE) is reported at high prevalence in selected autopsy case series of former contact 
sports athletes. Nevertheless, the contribution of CTE pathology to clinical presentation and its interaction with co-morbid 
neurodegenerative pathologies remain unclear. To address these issues, we performed comprehensive neuropathology assess-
ments on the brains of former athletes with dementia and considered these findings together with detailed clinical histories 
to derive an integrated clinicopathological diagnosis for each case. Consecutive, autopsy-acquired brains from former soc-
cer and rugby players with dementia were assessed for neurodegenerative pathologies using established and preliminary 
consensus protocols. Thereafter, next of kin interviews were conducted to obtain detailed accounts of the patient’s clinical 
presentation and course of disease to inform a final, integrated clinicopathological diagnosis. Neuropathologic change con-
sistent with CTE (CTE-NC) was confirmed in five of seven former soccer and three of four former rugby players’ brains, 
invariably in combination with mixed, often multiple neurodegenerative pathologies. However, in just three cases was the 
integrated dementia diagnosis consistent with CTE, the remainder having alternate diagnoses, with the most frequent inte-
grated diagnosis Alzheimer’s disease (AD) (four cases; one as mixed AD and vascular dementia). This consecutive autopsy 
series identifies neuropathologic change consistent with preliminary diagnostic criteria for CTE (CTE-NC) in a high propor-
tion of former soccer and rugby players dying with dementia. However, in the majority, CTE-NC appears as a co-morbidity 
rather than the primary, dementia causing pathology. As such, we suggest that while CTE-NC might be common in former 
athletes with dementia, in many cases its clinical significance remains uncertain.
Keywords Chronic traumatic encephalopathy · Traumatic brain injury · Neurodegeneration · Dementia · Alzheimer’s 
disease · Tau
Introduction
There is growing concern over the association between 
exposure to traumatic brain injury (TBI) and increased 
risk of a variety of neuropsychiatric and neurocognitive 
outcomes, in particular those linked to a specific neurode-
generative pathology known as chronic traumatic encepha-
lopathy (CTE) [11, 29, 31, 42, 50]. First recognized in the 
early part of the twentieth century as the punch drunk syn-
drome of boxers [24], it was not until descriptions of CTE in 
autopsy studies of non-boxer athletes that the lifelong con-
sequences of exposure to TBI attracted widespread attention 
[27, 36]. Nevertheless, despite this increased attention, there 
remain comparatively few accounts of the neuropathology 
of late survival from TBI [43]. As such, reflecting the rela-
tive paucity of cases described, consensus criteria for the 
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neuropathological assessment of CTE remain preliminary 
[26] and the associated clinical consequences of this pathol-
ogy remain unclear [48, 50].
In his report on the punch drunk syndrome, Harrison 
Martland provided the first, formal account of the chronic 
motor and neuropsychiatric consequences of exposure to 
repetitive mild TBI [24]. Thereafter, autopsy studies on sin-
gle cases and small case series described the neuropathology 
of dementia pugilistica (DP) as an apparently distinctive, 
perivascular deposition of hyperphosphorylated tau, in the 
form of neurofibrillary tangles [3, 4, 11, 12]. In addition, 
widespread amyloid-β (Aβ) plaques were reported in a 
majority [11, 40]. However, although isolated studies in non-
boxer individuals exposed to repetitive TBI were reported 
[6, 12], to the end of the twentieth century accounts of DP 
largely were restricted to observations in former boxers.
More recently, the pathology of DP, now termed CTE, 
has been documented in growing numbers of non-boxer 
athletes; the overwhelming majority from autopsy stud-
ies in former American footballers [28, 31], in addition to 
isolated descriptions of former athletes from a wide and 
growing range of sports [1, 9, 10, 22, 25, 37, 47], former 
military personnel [8, 38] and individuals exposed to a 
single moderate or severe TBI [15, 51]. Notably, many of 
these contemporary studies often describe more limited and 
localized pathology than historical case series of DP, with 
perhaps more attention on neuropsychiatric than cognitive 
symptomatology [42, 46]. Further, recent reporting largely 
focuses on tau pathologies in CTE over the constellation of 
non-tau proteinopathies that develop in late survivors from 
TBI. Reflecting this, preliminary consensus criteria for the 
neuropathological identification of CTE define the disease 
solely on the pattern and distribution of tau [26]. Finally, 
many reports often do not consider the clinical consequences 
of CTE pathology, particularly in patients with dementia 
where multiple neurodegenerative pathologies may co-exist.
There is, therefore, a continuing need to understand the 
complex neuropathology of late survival from exposure to 
TBI and its interaction with wider neurodegenerative pathol-
ogies. Herein, we report experience from a single institution 
on the neuropathological assessment of the largest series 
to date of former soccer (Association football) and rugby 
union (hereafter ‘rugby’) players with histories of dementia. 
Specifically, applying established and preliminary consensus 
criteria for neuropathological assessment of a range of neu-
rodegenerative diseases, together with detailed review of the 
clinical histories, we provide insight into the integrated clin-
icopathological diagnoses of dementia in a cohort of former 
athletes exposed to repetitive head impacts and mild TBI. 
Our observations suggest that CTE neuropathologic change 
(CTE-NC) is present in a high proportion of former soc-
cer and rugby players with dementia. However, considered 
together, the clinical features and neuropathologies support 
an integrated clinicopathologic diagnosis of CTE dementia 
(CTE-D) in only a small proportion of these cases.
Methods
Ethical approval and recruitment
Ethical approval for all procedures in this study was pro-
vided by: the University of Glasgow Medical Veterinary and 
Life Sciences College Ethics Committee (reference number 
200160147); the West of Scotland Research Ethics Commit-
tee (project ID 225271); and the Greater Glasgow and Clyde 
Biorepository (Application number 340). In each case, writ-
ten authorization for a hospital diagnostic autopsy and dona-
tion of brain tissue to the Glasgow TBI Archive for use in 
research was obtained from the next of kin. Nevertheless, to 
preserve patient confidentiality, specific details of individual 
cases are presented as summarized data, with age at disease 
onset and death presented in decades. Consecutive research 
brain donations spanning the period 2014–2018 were 
included: one case each from years 2014, 2015 and 2016; 
two from 2017; and six from 2018. No potential donors noti-
fied to the Archive over the period of accrual were excluded.
Neuropathological evaluation
At the time of autopsy, whole brains were immersion fixed 
in 10% formal saline for a minimum of 2 weeks, following 
which intact brains, where available, were transported to 
Glasgow for dissection and processing. For Case 1, only 
tissue blocks from target areas were available for review. 
Case 7 had been partially dissected prior to transport, but 
the complete specimen remained available for assessment. 
Following fixation, all brains were dissected, examined 
macroscopically and processed to paraffin using standard 
laboratory techniques. Tissue blocks for histopathological 
evaluation were sampled in line with standardized protocols 
for assessment of neurodegenerative disease. Specifically, 
sampled tissue blocks were sufficient to fulfill the minimum 
sampling recommended by the preliminary consensus cri-
teria for CTE [26].
From all tissue blocks, 8 μm sections were prepared and 
stained for Hematoxylin and eosin using standard laboratory 
techniques. In addition, in line with consensus protocols, 
sections from selected blocks were stained for: hyperphos-
phorylated tau (PHF-1; 1:1000; Dr P Davis), Aβ (6f3d; 1:75; 
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Dako), phosphorylated TDP-43 (1D3; 1:500; Millipore), 
alpha-synuclein (KM51; 1:200; Leica) and, where indi-
cated, 3-repeat (8E6/C11; 1:3000; Millipore) and 4-repeat 
tau (1E1/A6; 1:400; Millipore). Thereafter, stained sections 
were independently reviewed by two neuropathologists (KK, 
WS), blind to clinical history, and a consensus reached on 
the nature, extent and distribution of pathologies using 
established criteria for neuropathological assessment of 
neurodegenerative disease. Specifically, preliminary NINDS 
consensus diagnostic criteria were employed for assessment 
of CTE pathology [26], with CTE neuropathologic change 
(CTE-NC) confirmed where hyperphosphorylated tau was 
present in neurons, astrocytes and cell processes around 
small vessels in an irregular pattern and at the depths of 
cortical sulci. Further, although consensus staging criteria 
for CTE do not exist, where present, extent and distribution 
of CTE-NC were dichotomized as ‘low’ or ‘high’, corre-
sponding to stages I/II or III/IV, respectively, of a widely 
used protocol [28].
Verbal autopsy
Following completion of the neuropathology evaluation, 
face-to-face or telephone discussions (where face-to-face 
meeting was not practical) between the lead investigator 
(WS) and the next of kin were arranged. These comprised 
open ended, semi-structured interviews documenting a nar-
rative account of the patient’s clinical course, dementia diag-
nosis in life and management in the final illness. In addition, 
details were gathered on lifelong health (including exposure 
to TBI), history of participation in sport (including combat 
sports), medications, drug and alcohol exposure, family 
history and history of employment. At the culmination of 
this verbal autopsy, the comprehensive clinical information 
obtained was considered in context of the neuropathological 
features and a layered, diagnostic autopsy opinion provided, 
encompassing the final integrated diagnosis of dementia 
(clinicopathological diagnosis of dementia subtype) [21].
Statistics
Summary statistics and between-group differences were 
calculated using Minitab (Version 18.1, Minitab Inc.), with 
between-group differences assessed using the two-sample 
t-, Mann–Whitney or Kruskal–Wallis tests as appropriate.
Results
Demographic and background information
Eleven brain donations from former athletes with a history 
of dementia were received over the period of study (seven 
soccer; four rugby). Average age at onset of dementia was 
60 ± 8.6 years (range 48–75), with no difference in age of 
onset between former soccer (59.7 ± 8.1 years) or rugby 
(60.5 ± 10.8 years; p = 0.906) players, and similar disease 
durations (soccer 9.4 ± 4.5 years; rugby 11.2 ± 6.8 years; 
p = 0.657). Mixed playing positions were reported, with 
years of active participation in their sport estimated at 
23.8 ± 8.4 years (range 11–35 years; rugby 28.8 ± 6.5 years 
vs soccer 21 ± 8.5 years; p = 0.156). In five subjects, a 
Table 1  Cohort demographic information
AD Alzheimer’s disease, LOC loss of consciousness for less than 30 min, NDD neurodegenerative disease, PD Parkinson’s disease, PMI post-
mortem interval, TBI traumatic brain injury
Case no Sex Sport Position Other con-
tact sports
Estimated 
years in sport
History of TBI 
with LOC
Family history NDD PMI (days)
1 M Soccer Forward No 18 NA Nil NA
2 M Soccer Defense No 20 Yes Nil 11
3 M Soccer Defense No 35 Yes Nil 4
4 M Soccer Defense No 30 No Mother and brother ‘dementia’ 3
5 M Soccer Forward No 18 No Nil 1
6 M Soccer Defense Rugby 15 No Nil 3
7 M Soccer Defense No 11 No Mother PD 3
8 M Rugby Back No 20 Yes Nil 0.5
9 M Rugby Forward No 35 Yes Brother AD 2
10 M Rugby Forward No 32 Yes Nil 2
11 M Rugby Forward Soccer 28 No Nil 6
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history of previous TBI with brief loss of consciousness was 
reported; none required hospital admission and all would be 
compatible with ‘mild’ TBI/concussion. Full demographic 
information, including details of sports career and post-
mortem intervals, is provided in Table 1.
Neuropathology
Macroscopic appearances
Neuropathological evaluation revealed intact, fixed 
brain weights typically low (soccer 1225 ± 118 g; rugby 
1224 ± 120 g; p = 0.989), with associated atrophy of frontal 
and temporal lobes (Fig. 1a) and hydrocephalus ex vacuo. In 
addition, moderate atrophy of the heads of the caudate nuclei 
was noted in Case 11. Septum pellucidum abnormalities 
were present in five cases, as fenestrated (Fig. 1b) or cavum 
septum or as mixed fenestrated and cavum (Table 2). Evi-
dence of old, focal ischemic pathology as cavitated infarcts 
was noted in four cases. However, no focal pathology con-
sistent with previous traumatic brain injury was present; 
specifically, no healed contusions were identified.
Microscopic appearances
Histological examination revealed a variety of neuropatholo-
gies, including those fulfilling criteria for multiple neurode-
generative pathologies (Table 2). Evidence of old ischemic 
injuries was confirmed in Cases 2, 4, 5, 9 and 10 as variably 
sized foci of architectural disturbance with neuronal loss 
and astrocytic gliosis, occasionally with cystic degeneration 
and an established glial limitans. Bilateral hippocampal scle-
rosis was also present in Case 2. Marked substantia nigra 
pigment incontinence, neuronal loss and astrocytic gliosis 
were noted in Cases 3, 7 and 11, and occasional remaining 
neurons containing either classical Lewy bodies (Case 3) or 
globose tangles (Cases 7 and 11).
Hyperphosphorylated tau
All 11 brains showed abnormal hyperphosphorylated tau 
(p-tau) pathology, consistent with several distinct tauopa-
thies [17]. In eight cases (five soccer, three rugby), p-tau 
was present in a patchy distribution towards the depths of 
cortical sulci as neurofibrillary tangles, neurites and thorn-
shaped astrocytes clustered around cortical vessels, fulfill-
ing the preliminary consensus neuropathological criteria for 
the recognition of CTE (Figs. 1c, d, 2a, b) [26]. Notably, 
patients in whom CTE neuropathological change (CTE-NC) 
was present were generally older at disease onset (median 
63.5 years vs 50 years; p = 0.019; Mann–Whitney) and 
at death (74.5 years vs 59 years; p = 0.041) than patients 
without CTE-NC. There was no difference in disease dura-
tion between cases with or without CTE-NC (10.5 years vs 
8.7 years; p = 0.610).
In addition to CTE-NC, neurofibrillary tangle pathology 
in wider distribution was present in six former soccer and 
three former rugby players, consistent with AD Braak stage 
III to VI pathology [2]. In the remaining two cases, p-tau 
pathologies appeared as 4R tau-positive, 3R tau-negative, 
neuronal cytoplasmic inclusions, neurites, coiled bodies, 
and tufted astrocytes, or as astrocytic plaques, ballooned 
cells, and pre-tangles, consistent with pathologic diagnoses 
of progressive supranuclear palsy (PSP) [23] or corticobasal 
degeneration (CBD), respectively [5]. Finally, subcortical, 
periventricular, subpial or peri-infarct p-tau immunoreac-
tive, and thorn-shaped astrocytes were present in five cases, 
typical of aging-related tau astrogliopathy (ARTAG) [19, 
20].
Amyloid‑β
Screening for amyloid-β (Aβ) pathologies revealed abnor-
malities in eight cases (five soccer, three rugby). In seven 
examples, these appeared as moderate to frequent, mixed 
diffuse and neuritic plaques (CERAD B or C) [32], typi-
cally in wide distribution (Thal phase 4 or 5) (Figs. 1e, 2c) 
Fig. 1  Representative macroscopic and histologic images from Case 
8, a former rugby union player who first presented in his 50  s with 
a change in behavior marked by increasing levels of frustration and 
agitation associated with aggressive outbursts. In the following years, 
these behavioral and personality symptoms progressed, with cogni-
tive disturbance evolving late in the course of disease. The patient 
died in his 70 s, 18 years after first presentation. On examination of 
the whole brain, there is gyral atrophy with associated sulcal thin-
ning, most evident in frontal lobes (a). Sectioning the brain in the 
coronal plain through the mammillary bodies reveals ventriculomeg-
ally, consistent with the atrophy noted externally, in addition to fenes-
tration of the septum pellucidum (b; white arrow). Staining sections 
for hyperphosphorylated tau (p-tau; PHF1) reveal widespread corti-
cal immunoreactivity, within which are multiple patches of increased 
staining density towards the depths of cortical sulci (c), which on 
higher power are seen to coincide with neuronal and astroglial immu-
noreactive profiles clustered around small blood vessels (d; black 
arrows). In addition to widespread p-tau pathology, numerous Aβ 
plaques are present (e; 6f3d). The final integrated dementia diagnosis 
was CTE-D
◂
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[49], while in one case more localized (Thal phase 2) dif-
fuse plaques were identified. In addition, cerebral amyloid 
angiopathy (CAA) was present in seven Aβ plaque-positive 
cases, typically of high severity by routinely employed his-
tological assessment protocols [35].
TDP‑43
Staining for phosphorylated TDP-43 revealed scattered neu-
ronal cytoplasmic inclusions and neurites in seven brains, 
consistent with stage 3, 4 or 5 TDP-43 pathology [16]. This 
included Case 2, in which there was noted bilateral hip-
pocampal sclerosis, supporting a pathological diagnosis of 
hippocampal sclerosis of aging [34]. The remaining cases 
were negative for TDP-43.
Alpha‑synuclein
Alpha-synuclein-positive profiles were present in just two 
brains. In Case 3, abundant synuclein-immunoreactive neu-
rites and neuronal cytoplasmic inclusions consistent with 
cortical Lewy bodies were present, supporting a neuropatho-
logic diagnosis of diffuse neocortical pattern of Lewy body 
disease (Fig. 2d–f) [30, 39]. Case 5 exhibited classical Lewy 
bodies, with sparse synuclein-positive neurites and neurons 
in the cingulate gyrus, medial temporal lobe and amygdala 
supporting a diagnosis of limbic/transitional pattern Lewy 
body disease [30].
Summary of neuropathologies
Thus, multiple, mixed neurodegenerative pathologies 
were typical in these former soccer and rugby players with 
dementia. In some form, p-tau pathologies were identified 
in all cases. Thereafter, Aβ pathologies were present in 73%, 
TDP-43 in 64%, vascular pathology in 55% and alpha-synu-
clein in 18%. Deposition of p-tau in a pattern and distri-
bution fulfilling preliminary neuropathological criteria for 
CTE was present in eight cases, all but one of which also 
showed mixed p-tau and Aβ pathologies in keeping with 
Alzheimer’s disease neuropathologic changes (ADNC), with 
seven cases in total showing ‘high/intermediate’ ADNC and 
a single case with ‘low’ ADNC [33]. In addition to plaque 
pathology, widespread CAA was present in seven brains, five 
of which showed features of macro- and/or micro-vascular 
ischemic pathology. A further two cases had evidence of 
ischemic pathology in the absence of CAA. All five cases 
with abnormalities in the septum pellucidum had co-existent 
CTE neuropathology.
Integrated clinicopathological diagnosis
Following neuropathological evaluation, verbal autopsy 
interviews with the donor’s next of kin, supplemented by 
clinical case records’ review, where available, provided com-
prehensive accounts of the clinical presentation and disease 
course (summarized in Table 3), which informed a final, 
integrated clinicopathological diagnosis of dementia subtype 
for each case. The most frequent integrated diagnosis was 
Table 2  Neuropathological observations
AD Alzheimer’s disease, ADNC Alzheimer’s disease neuropathologic changes, ARTAG aging-related tau astrogliopathy, C cavum, CAA cerebral 
amyloid angiopathy [35]; CBD corticobasal degeneration,CPC clinicopathological correlation, CTE-NC chronic traumatic encephalopathy neu-
ropathologic change, CVD chronic cerebrovascular disease, DLB dementia with Lewy bodies, F fenestrated, NA not assessed, ND neurodegener-
ative disease, PART primary age-related tauopathy, PSP progressive supranuclear palsy, TDP-43 abnormally phosphorylated TDP-43 pathology 
[16], VaD vascular dementia
Case no Sport Septum CTE-NC ADNC CAA TDP-43 Other ND pathology Clinical diagnosis Integrated CPC diagnosis
A B C
1 Soccer F + C High 1 2 0 4 – CVD AD CTE
2 Soccer C High 0 2 0 0 5 CVD; PART AD VaD
3 Soccer F High 2 3 3 2.25 – DLB AD DLB
4 Soccer NA High 3 3 2 0 4 CVD; ARTAG Mixed AD/VaD CTE
5 Soccer C Low 3 3 2 3.5 3 CVD; DLB; ARTAG Mixed AD/VaD AD
6 Soccer Intact No 3 3 3 4 – ARTAG ‘early onset dementia’ AD
7 Soccer Intact No 0 0 0 0 4 PSP AD PSP
8 Rugby F High 3 3 2 3 5 ARTAG VaD CTE
9 Rugby F Low 3 3 3 4 4 CVD; ARTAG AD AD
10 Rugby Intact Low 2 3 3 0.25 3 CVD AD Mixed AD/VaD
11 Rugby Intact No 0 0 0 0 – CBD CTE CBD
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Alzheimer’s disease (AD; four cases; one as mixed AD and 
vascular dementia), followed by three cases with demen-
tia compatible with CTE (CTE-D). Of the remaining cases, 
these included one case each of vascular dementia, dementia 
with Lewy bodies, PSP and CBD. Thus, within this cohort, 
three broad diagnostic categories might be proposed, dis-
tinguished by the presence of CTE-NC and its association 
with dementia diagnosis. These consist of: (1) patients 
with dementia but no evidence of CTE-NC (n = 3; median 
age onset 50 years); (2) patients with an integrated diag-
nosis of CTE-D (n = 3; median 55 years); and (3) patients 
with CTE-NC as co-morbidity in context of an alternate 
integrated diagnosis (n = 5; median 66 years; p = 0·024; 
Kruskal–Wallis).
Discussion
Herein, we present observations on neurodegenerative 
pathologies and their relationship to the final integrated, 
clinicopathological dementia diagnosis in a consecutive 
series of 11 brain donations from former soccer and rugby 
union players with dementia. In addition to ubiquitous tau 
pathologies, our cases invariably showed mixed, often mul-
tiple, co-existent neurodegenerative pathologies, including 
frequent Aβ pathologies as amyloid plaques and cerebral 
amyloid angiopathy. Further, although the pathognomonic 
neuropathology of CTE described within preliminary con-
sensus criteria was present in a high proportion of brains 
in this series, in only three would CTE be regarded as the 
primary integrated dementia diagnosis following compre-
hensive review of the clinical histories and neuropatholo-
gies. In the remaining five cases with CTE neuropathologic 
change (CTE-NC), this appeared as co-morbid pathology in 
the setting of an alternative integrated dementia diagnosis. 
Thus, in context of dementia arising in athletes exposed to 
repetitive mild traumatic brain injury, three distinct clinico-
pathological groupings are suggested by this series defined 
by the presence of CTE-NC and its relationship to the final 
integrated dementia diagnosis. These observations support 
the need for comprehensive neuropathological evaluation 
and reporting in individuals exposed to TBI, with distinc-
tion between the autopsy finding of CTE-NC and the puta-
tive clinical consequences of this pathology, including CTE 
dementia (CTE-D).
Notably, mixed neurodegenerative pathologies were pre-
sent in nine of our series, even in relatively younger aged 
patients. Mixed pathologies increasingly are recognized 
in studies of neurodegenerative disease [18, 41, 44], with 
prevalence estimates ranging up to 80% of dementias at 
autopsy and directly correlated with age [41]. In contrast to 
our experience, previous series report mixed neurodegen-
erative pathologies in just 45% of former athletes [31]. In 
this respect, mixed pathologies appear more frequent in our 
patients than in similar studies in former athletes, perhaps 
reflecting an older patient cohort. Conceivably, such mixed 
neurodegenerative pathologies might contribute to clinically 
‘atypical’ presentations, leading to challenges in establish-
ing accurate clinical diagnoses. There is undoubtedly a need 
for continued autopsy brain examination in individuals sur-
viving TBI, with accurate and comprehensive documenta-
tion of the full spectrum of pathologies encountered in each 
examination.
Reporting in CTE largely focuses on p-tau pathologies. 
Indeed, preliminary consensus criteria define pathogno-
monic CTE neuropathology solely by the pattern and distri-
bution of p-tau [26]. While pathognomonic p-tau patholo-
gies were common in our current series, Aβ pathology 
as plaque and/or CAA was as frequent and present in all 
but one case with CTE-NC. In contrast, studies on former 
American footballers with CTE document Aβ pathology in 
just 61% [45]. However, incidence of dementia was reported 
higher in those older American footballers in which there 
were high burdens of CTE and Aβ. In this context, our data 
support these observations and might suggest that few post-
TBI dementias arise in context of a pure tauopathy (pure 
CTE-NC), the majority arising in context of mixed pro-
teinopathies, including frequent Aβ pathologies. As such, 
dementia-associated neurodegenerative pathology in former 
athletes might be more reminiscent of AD.
Since the first description of CTE in a former American 
football player [36], there has been a proliferation in autopsy 
series reporting its presence in individuals surviving a spec-
trum of TBI exposures (for review, see Hay et al. [11]). Nev-
ertheless, the published case experience in CTE remains low 
[43], with reports typically documenting CTE pathology, 
but including little interpretation of its clinical implications. 
By example, an autopsy series documenting 110 of 111 for-
mer National Football League (NFL) American footballers 
with CTE pathology offered no insights into final integrated 
clinicopathological diagnoses [31]. Similarly, no opinion on 
final, integrated clinicopathological diagnoses after neuro-
pathological evaluation was provided in a study of six for-
mer soccer players with dementia, four of whom had CTE 
neuropathology [22]. We identified CTE-NC in eight of our 
11 former athletes with dementia. However, in just three of 
these cases was the integrated, primary dementia diagnosis 
consistent with CTE dementia (CTE-D) after consideration 
of the comprehensive clinical information. As such, while 
CTE-NC is a common pathology in former contact sports 
athletes with dementia, CTE-D appears a less common pri-
mary dementia diagnosis.
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In this series of former soccer and rugby players with 
dementia, CTE-NC was present in 73% of cases. Adding this 
experience to observations in previous, isolated case reports 
in rugby and soccer, where sought, autopsy confirmed CTE 
pathology is reported in 75% of former athletes from these 
sports: 13/18 (seven from this study) soccer [1, 6, 9, 10, 
22, 25] and 5/6 (four from this study) rugby [25, 45]. Else-
where, CTE neuropathology has been reported ranging from 
50% (7/14) of former boxers [7] to 99% (110/111) of former 
NFL footballers examined [31]. Although such studies are 
subject to numerous biases and limitations, rendering them 
uninformative regarding true disease prevalence, the appar-
ent variation in reported prevalence of CTE neuropathology 
between these autopsy series might suggest between sports’ 
differences in risk and/or variability in methodologies of 
specimen accrual and neuropathology assessment between 
laboratories.
In summary, our observations suggest that while CTE-NC 
may be a common pathology in former soccer and rugby 
players with dementia, CTE dementia appears a less com-
mon primary dementia diagnosis. Current criteria for AD 
distinguish neurodegenerative pathologies, defined as AD 
neuropathologic changes (ADNC) [13, 33], from the clini-
cal syndrome of dementia of Alzheimer’s disease type [14]. 
Reflecting this approach, we propose that there should be 
a similar distinction between CTE neuropathologic change 
and the clinical consequences of this pathology, including 
CTE dementia. As experience grows, CTE-NC conceivably 
might echo experience in AD, where the neuropathologic 
change can represent incidental pathology without clinical 
effect, or the major pathology driving clinical dementia phe-
notypes, or a co-morbid pathology within mixed neurode-
generative disease. In other words, in the absence of clinical 
correlation, CTE neuropathologic change should perhaps be 
regarded as a pattern of pathology, rather than diagnostic of 
a specific disease.
Fig. 2  Representative images from Case 3, a former soccer player 
who first came to attention in his 60  s with mild cognitive impair-
ment. There followed a steady progression in these symptoms, with 
exacerbations in the post-operative period, and with the develop-
ment of visual hallucinations and motor signs leading to a clinical 
suspicion of Parkinson’s disease, or related disorder. After an 8-year 
course, the patient died in his 70 s. Staining for p-tau reveals patches 
of neuronal and astroglial immunoreactivity at the depths of cortical 
sulci (a), which on higher power are clustered around small cortical 
vessels (b; PHF1). Frequent Aβ plaques are also present (c; 6f3d). 
In addition, staining for alpha-synuclein reveals extensive cortical 
staining (d), with numerous cortical Lewy bodies present (e; black 
arrows). Sections of the midbrain also reveal scattered classical 
Lewy bodies (f; white arrow) within remaining pigmented neurons 
of the substantia nigra. Given the stereotypical clinical presentation 
and associated neuropathological features, an integrated diagnosis 
of dementia with Lewy bodies was made, with co-morbid CTE-NC 
noted
◂
Table 3  Major clinical symptoms reported
Case no Age 
symptom 
onset
Age at death Disease 
duration 
(years)
Major symptoms at presentation and over disease course
1 50 s 50 s 5 Behavioral change and personality change (impulsivity) at onset; progression to cognitive 
impairment (memory) late in disease
2 60 s 60 s 7 Mild, but evolving cognitive impairment (memory) at onset; acute stroke with cognitive 
deterioration later in disease and stepwise deterioration thereafter
3 60 s 70 s 8 Cognitive impairment (problem solving) at onset; acute deterioration post-operatively; Par-
kinsonism and visual hallucinations late in course
4 60 s 70 s 10 Behavioral change with aggression and cognitive impairment (memory) at onset; Reduced 
mobility late in disease
5 60 s 80 s 16 Loss of confidence associated with cognitive impairment (spatial awareness) at onset; pro-
gressing memory impairment; sleep and behavioral disturbance late in course
6 50 s 50 s 6 Cognitive impairment (memory; conceptual) at onset; behavioral change later as mild disin-
hibition
7 50 s 60 s 13 Behavioral change at onset; progressing to memory decline and motor symptoms
8 50 s 70 s 18 Behavioral and personality change (short tempered; irritable; loss of confidence); memory 
impairment late in disease
9 60 s 70 s 16 Cognitive impairment (memory) at onset; gradual decline with evolving cognitive symptoms 
thereafter; not behavioral symptoms
10 70 s 70 s 4 Cognitive impairment post diagnosed lacunar infarct at onset; decline thereafter
11 50 s 50 s 7 Behavioral change (becoming introverted) and mild cognitive (memory) symptoms at onset; 
motor symptoms (shuffling gait) and speech loss with progression
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